The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Five National Surgical Adjuvant Breast and Bowel Project Node-Positive Adjuvant Breast Cancer Trials
Abstract
Purpose: Locoregional failure after breast-conserving surgery is associated with increased risk of distant disease and death. The magnitude of this risk in patients receiving chemotherapy has not been adequately characterized. Patients and Methods: Our study population included 2,669 women randomly assigned onto five National Surgical Adjuvant Breast and Bowel Project node-positive protocols (B-15, B-16, B-18, B-22, and B-25), who were treated with lumpectomy, whole-breast irradiation, and adjuvant systemic therapy. Cumulative incidences of ipsilateral breast tumor recurrence (IBTR) and other locoregional recurrence (oLRR) were calculated. Kaplan-Meier curves were used to estimate distant–disease-free survival (DDFS) and overall survival (OS) after IBTR or oLRR. Cox models were used to model survival using clinical and pathologic factors jointly with IBTR or oLRR as time-varying predictors. Results: Four hundred twenty-four patients (15.9%) experienced locoregional failure; 259 (9.7%) experienced IBTR, and 165 (6.2%) experienced oLRR. The 10-year cumulative incidence of IBTR and oLRR was 8.7% and 6.0%, respectively. Most locoregional failures occurred within 5 years (62.2% for IBTR and 80.6% for oLRR). Age, tumor size, and estrogen receptor status were significantly associated with IBTR. Nodal status and estrogen and progesterone receptor status were significantly associated with oLRR. The 5-year DDFS rates after IBTR and oLRR were 51.4% and 18.8%, respectively. The 5-year OS rates after IBTR and oLRR were 59.9% and 24.1%, respectively. Hazard ratios for mortality associated with IBTR and oLRR were 2.58 (95% CI, 2.11 to 3.15) and 5.85 (95% CI, 4.80 to 7.13), respectively. Conclusion: Node-positive breast cancer patients who developed IBTR or oLRR had significantly poorer prognoses than patients who did not experience these events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022152 · Cited by 6,249
Self-citationA Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Fisher, B., Brown, A., Mamounas, E., Wieand, S., Robidoux, A., Margolese, R. G., Cruz, A. B., Fisher, E. R., Wickerham, D. L., Wolmark, N., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2483 · Cited by 1,801
Self-citationvan Dongen, J. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1143 · Cited by 1,271
Jacobson, J. A., Danforth, D. N., Cowan, K. H., d'Angelo, T., Steinberg, S. M., Pierce, L., Lippman, M. E., Lichter, A. S., Glatstein, E., & Okunieff, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321402 · Cited by 892
Fisher, B., Brown, A. M., Dimitrov, N. V., Poisson, R., Redmond, C., Margolese, R. G., Bowman, D., Wolmark, N., Wickerham, D. L., & Kardinal, C. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1483 · Cited by 620
Self-citationSurgical margins in patients with early-stage breast cancer treated with breast conservation therapy
Singletary, S. E. (2002) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)01012-7 · Cited by 612
Voogd, A. C., Nielsen, M., Peterse, J. L., Blichert-Toft, M., Bartelink, H., Overgaard, M., van Tienhoven, G., Andersen, K. W., Sylvester, R. J., van Dongen, J. A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1688 · Cited by 562
Sarrazin, D., Lê, M. G., Arriagada, R., Contesso, G., Fontaine, F., Spielmann, M., Rochard, F., Le Chevalier, T., & Lacour, J. (1989) · Radiotherapy and Oncology · doi:10.1016/0167-8140(89)90165-5 · Cited by 561
Significance of ipsilateral breast tumour recurrence after lumpectomy
Fisher, B., Anderson, S., Fisher, E. R., Redmond, C., Wickerham, D. L., Wolmark, N., Mamounas, E. P., Deutsch, M., & Margolese, R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90475-5 · Cited by 556
Self-citationPark, C. C., Mitsumori, M., Nixon, A., Recht, A., Connolly, J., Gelman, R., Silver, B., Hetelekidis, S., Abner, A., Harris, J. R., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1668 · Cited by 548
山口, 博. (2006) · Mebio oncology · Cited by 516
Veronesi, U., Marubini, E., Vecchio, M. D., Manzari, A., Andreola, S., Greco, M., Luini, A., Merson, M., Saccozzi, R., Rilke, F., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.1.19 · Cited by 505
Kurtz, J. M., Amalric, R., Brandone, H., Ayme, Y., Jacquemier, J., Pietra, J.-C., Hans, D., Pollet, J.-F., Bressac, C., & Spitalier, J.-M. (1989) · Cancer · doi:10.1002/1097-0142(19890515)63:10<1912::aid-cncr2820631007>3.0.co;2-y · Cited by 423
Clarke, D. H., G. Lê, M., Sarrazin, D., Lacombe, M.-J., Fontaine, F., Travagli, J.-P., May-Levin, F., Contesso, G., & Arriagada, R. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90372-4 · Cited by 408
Blichert-Toft, M., Rose, C., Andersen, J. A., Overgaard, M., Axelsson, C. K., Andersen, K. W., & Mouridsen, H. T. (1992) · PubMed · Cited by 371
Schnitt, S. J., Connolly, J. L., Harris, J. R., Hellman, S., & Cohen, R. B. (1984) · Cancer · doi:10.1002/1097-0142(19840301)53:5<1049::aid-cncr2820530506>3.0.co;2-o · Cited by 354
Smith, T. E., Lee, D., Turner, B. C., Carter, D., & Haffty, B. G. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01378-x · Cited by 312
Fisher, B., Anderson, S., Wickerham, D. L., DeCillis, A., Dimitrov, N., Mamounas, E., Wolmark, N., Pugh, R., Atkins, J. N., Meyers, F. J., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1858 · Cited by 308
Self-citationFisher, B., Redmond, C., Legault-Poisson, S., Dimitrov, N. V., Brown, A. M., Wickerham, D. L., Wolmark, N., Margolese, R. G., Bowman, D., & Glass, A. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.6.1005 · Cited by 291
Self-citationTouboul, E., Buffat, L., Belkacémi, Y., Lefranc, J.-P., Uzan, S., Lhuillier, P., Faivre, C., Huart, J., Lotz, J.-P., Antoine, M., et al. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00365-4 · Cited by 271
FISHER, E. R., Anderson, S., Redmond, C. K., & Fisher, B. (1992) · PubMed · Cited by 268
Self-citationHuang, E., Buchholz, T. A., Meric, F., Krishnamurthy, S., Mirza, N. Q., Ames, F. C., Feig, B. W., Kuerer, H. M., Ross, M. I., Singletary, S. E., et al. (2002) · Cancer · doi:10.1002/cncr.10952 · Cited by 257
Fortin, A., Larochelle, M., Laverdière, J., Lavertu, S., & Tremblay, D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.101 · Cited by 250
The influence of young age on outcome in early stage breast cancer
Fowble, B. L., Schultz, D. J., Overmoyer, B., Solin, L. J., Fox, K., Jardines, L., Orel, S., & Glick, J. H. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90515-0 · Cited by 241
Fisher, B., Anderson, S., DeCillis, A., Dimitrov, N., Atkins, J. N., Fehrenbacher, L., Henry, P. H., Romond, E. H., Lanier, K. S., Davila, E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3374 · Cited by 225
Self-citationWhelan, T., Clark, R., Roberts, R., Levine, M., & Foster, G. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90513-4 · Cited by 210
Abner, A. L., Recht, A., Eberlein, T., Come, S., Shulman, L., Hayes, D., Connolly, J. L., Schnitt, S. J., Silver, B., & Harris, J. R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.44 · Cited by 200
Meric, F., Mirza, N. Q., Vlastos, G., Buchholz, T. A., Kuerer, H. M., Babiera, G. V., Singletary, S. E., Ross, M. I., Ames, F. C., Feig, B. W., et al. (2003) · Cancer · doi:10.1002/cncr.11222 · Cited by 198
Evans, R. A. (2003) · Cancer · doi:10.1002/cncr.11792 · Cited by 173
Borner, M., Bacchi, M., Goldhirsch, A., Greiner, R., Harder, F., Castiglione, M., Jungi, W. F., Thürlimann, B., Cavalli, F., & Obrecht, J. P. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2071 · Cited by 162
Arriagada, R., Lê, M. G., Contesso, G., Guinebretière, J., Rochard, F., & Spielmann, M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf227 · Cited by 104
Evaluating Serial Cancer Marker Studies in Patients at Risk of Recurrent Disease
Gail, M. H. (1981) · Biometrics · doi:10.2307/2530523 · Cited by 99
Local-Regional Breast Cancer Recurrence: Prognostic Groups Based on Patterns of Failure
Moran, M. S., & Haffty, B. G. (2002) · The Breast Journal · doi:10.1046/j.1524-4741.2002.08202.x · Cited by 88
Fredriksson, I., Liljegren, G., Arnesson, L.-G., Emdin, S. O., Palm-Sjövall, M., Fornander, T., Holmqvist, M., Holmberg, L., & Frisell, J. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00219-8 · Cited by 85
Survival Following Locoregional Recurrence After Breast Conservation Therapy for Cancer
Stotter, A. T., Atkinson, E. N., FAIRSTON, B. A., McNeese, M. D., Oswald, M. J., & Balch, C. M. (1990) · Annals of Surgery · doi:10.1097/00000658-199008000-00009 · Cited by 66
Dalberg, K., Mattsson, A., Rutqvist, L. E., Johansson, U., Riddez, L., & Sandelin, K. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005732224717 · Cited by 50
Cited by
Smith, B. D., Arthur, D. W., Buchholz, T. A., Haffty, B. G., Hahn, C. A., Hardenbergh, P. H., Julian, T. B., Marks, L. B., Todor, D. A., Vicini, F. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.031 · Cited by 872
Nguyen, P. L., Taghian, A. G., Katz, M. S., Niemierko, A., Abi Raad, R. F., Boon, W. L., Bellon, J. R., Wong, J. S., Smith, B. L., & Harris, J. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4287 · Cited by 811
Wapnir, I. L., Dignam, J. J., Fisher, B., Mamounas, E. P., Anderson, S. J., Julian, T. B., Land, S. R., Margolese, R. G., Swain, S. M., Costantino, J. P., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr027 · Cited by 785
Self-citationComparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
Turnbull, L., Brown, S., Harvey, I., Olivier, C., Drew, P., Napp, V., Hanby, A., & Brown, J. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62070-5 · Cited by 642
Mamounas, E. P., Tang, G., Fisher, B., Paik, S., Shak, S., Costantino, J. P., Watson, D., Geyer, C. E., Wickerham, D. L., & Wolmark, N. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7610 · Cited by 619
Self-citation
Metadata
- Authors
- Wapnir, I. L., Anderson, S. J., Mamounas, E. P., Geyer, C. E., Jeong, J.-H., Tan-Chiu, E., Fisher, B., & Wolmark, N.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-05-01
- Volume
- 24
- Issue
- 13
- Pages
- 2028-2037
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2172198909
- Cited by
- 466
- References
- 43
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.